(Q35192420)

7 August 2017

1 reference

title

Molecular biology of transitional cell carcinoma (English)

1 reference

7 August 2017

1 reference

Sana Al-Sukhun

1

1 reference

PubMed ID

12900011

7 August 2017

Maha Hussain

series ordinal

2

1 reference

7 August 2017

1 August 2003

1 reference

Critical Reviews in Oncology Hematology

7 August 2017

1 reference

7 August 2017

47

1 reference

7 August 2017

181-193

1 reference

7 August 2017

2

1 reference

7 August 2017

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Mapping of the urinary bladder: Its impact on the concepts of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

NATURAL HISTORY AND CLINICAL BEHAVIOR OF IN SITU CARCINOMA OF THE HUMAN URINARY BLADDER

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

The Pathology of Human Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Chromosome 21q22 deletion. A specific chromosome change in a new bladder cancer subgroup

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Human genome studies expected to revolutionize cancer classification

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Microsatellite instability in cancer of the proximal colon

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Functional analysis of the mismatch repair system in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Microsatellite instability in transitional cell carcinoma of the urinary tract and its relationship to clinicopathological variables and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Microsatellite alterations in urinary sediments from patients with cystitis and bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Role of the retinoblastoma protein in the pathogenesis of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Function of a human cyclin gene as an oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

The epidermal growth factor receptor and the prognosis of bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Expression of epidermal growth factor receptor in urinary bladder cancer metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

C-ERBB-2 gene amplification as a prognostic marker in human bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Detection of the c-myc gene product in urinary bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Restriction fragment length polymorphism of the L-myc gene is not a prognostic factor in bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

p53 and bcl-2 overexpression as associated risk factors in patients 40 years old or less with transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

The p53 proto-oncogene can act as a suppressor of transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Implications of the p53 tumor-suppressor gene in clinical oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Different tumor-derived p53 mutants exhibit distinct biological activities

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Telomerase activity in human urothelial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Transitional cell carcinoma expresses high levels of Fas ligand in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Bladder cancer detection with urinary survivin, an inhibitor of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Angiogenesis in urological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Quantification of angiongenesis as an independent predictor of prognosis in invasive bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Novel growth regulatory factors and tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Expression of platelet-derived endothelial cell growth factor in bladder carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

The pathogenesis of cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

The monoclonal antibody BQ16 identifies the alpha 6 beta 4 integrin on bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Collagen IV staining pattern in bladder carcinomas: relationship to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Value of immunohistochemical laminin staining in transitional cell carcinoma of human bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Autocrine motility factor is a growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Detection of autocrine motility factor in urine as a marker of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

An Immunohistochemical and Prognostic Evaluation of Cathepsin D Expression in 105 Bladder Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2803%2900081-7

7 January 2021

10.1016/S1040-8428(03)00081-7

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12900011